
Sign up to save your podcasts
Or
In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.
3.7
33 ratings
In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.
775 Listeners
316 Listeners
21,923 Listeners
498 Listeners
136 Listeners
55 Listeners
180 Listeners
2 Listeners
3,657 Listeners
9 Listeners
56 Listeners
0 Listeners
1,608 Listeners
0 Listeners
2 Listeners